Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32018R1796

Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron (Text with EEA relevance.)

C/2018/7577

OJ L 294, 21.11.2018, p. 15–17 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

In force

ELI: http://data.europa.eu/eli/reg_impl/2018/1796/oj

21.11.2018   

EN

Official Journal of the European Union

L 294/15


COMMISSION IMPLEMENTING REGULATION (EU) 2018/1796

of 20 November 2018

amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,

Whereas:

(1)

Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

(2)

The approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl and pyraclostrobin were last extended by Commission Implementing Regulation (EU) 2018/84 (3). The approval periods of those substances will expire on 31 January 2019.

(3)

The approval period of the active substance tritosulfuron will expire on 30 November 2018.

(4)

The approval periods of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-p, fenpropidin, lenacil, nicosulfuron, picloram and pyriproxyfen will expire on 31 December 2018.

(5)

Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (4).

(6)

Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.

(7)

In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.

(8)

Taking into account that the approval period of the active substance tritosulfuron expires on 30 November 2018, this Regulation should enter into force as soon as possible.

(9)

Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(10)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 20 November 2018.

For the Commission

The President

Jean-Claude JUNCKER


(1)  OJ L 309, 24.11.2009, p. 1.

(2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

(3)  Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, clothianidin, copper compounds, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl, pethoxamid, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide (OJ L 16, 20.1.2018, p. 8).

(4)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).


ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2020’;

(2)

in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2020’;

(3)

in the sixth column, expiration of approval, of row 111, Chlorpyrifos, the date is replaced by ‘31 January 2020’;

(4)

in the sixth column, expiration of approval, of row 112, Chlorpyrifos-methyl, the date is replaced by ‘31 January 2020’;

(5)

in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2020’;

(6)

in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2020’;

(7)

in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2020’;

(8)

in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2020’;

(9)

in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2019’;

(10)

in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2019’;

(11)

in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2019’;

(12)

in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2019’;

(13)

in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2019’;

(14)

in the sixth column, expiration of approval, of row 174, Diflubenzuron, the date is replaced by ‘31 December 2019’;

(15)

in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2019’;

(16)

in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2019’;

(17)

in the sixth column, expiration of approval, of row 179, Pyriproxyfen, the date is replaced by ‘31 December 2019’;

(18)

in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2019’;

(19)

in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2019’;

(20)

in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2019’;

(21)

in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2019’;

(22)

in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2019’.


Top